Low-molecular-weight heparins and cancer: focus on antitumoral effect.
about
The evolution of anticoagulant therapyMechanisms of heparanase inhibitors in cancer therapy.Enhanced eryptosis contributes to anemia in lung cancer patientsAntithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.Repeated Oral or Subcutaneous LMWH Has similar Antithrombotic Activity in a Rat Venous Thrombosis Model: Antithrombotic Activity Correlates With Heparin on Endothelium When Orally Administered.Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis.
P2860
Q26771859-95B8A6FB-57CB-4232-9505-566E92D8BEEBQ30244089-7D32FAF1-A46D-47E8-8784-93EC310245D6Q37046509-153813FF-F215-4831-9C0B-5316718CCA39Q40714729-03FF4D07-6AA1-49A7-9AF0-FA1CA7A2E472Q48171089-254AC16E-6980-4290-8B78-945B9C407106Q51800038-C8DF51F0-704F-4D10-87E7-DF8316DE2931Q53129247-53E79324-A79C-4EF1-8F89-28E30C27B1EA
P2860
Low-molecular-weight heparins and cancer: focus on antitumoral effect.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low-molecular-weight heparins and cancer: focus on antitumoral effect.
@en
type
label
Low-molecular-weight heparins and cancer: focus on antitumoral effect.
@en
prefLabel
Low-molecular-weight heparins and cancer: focus on antitumoral effect.
@en
P2860
P1433
P1476
Low-molecular-weight heparins and cancer: focus on antitumoral effect.
@en
P2860
P304
P356
10.3109/07853890.2015.1004361
P407
P577
2015-03-13T00:00:00Z